Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Thoratec Reports 44 Percent Increase in Third Quarter Revenues
Date:10/30/2008
Income (loss)
from operations 8,187 (2,380) 18,404 (3,217)
Other income and
(expense):
Interest expense (1,009) (1,016) (3,030) (3,158)
Interest income
and other 2,183 2,261 6,642 6,214
Income (loss) before
income taxes 9,361 (1,135) 22,016 (161)
Income tax expense (2,179) (273) (5,834) (269)
Net income (loss) $7,182 $(1,408) $16,182 $(430)
Net income (loss)
per share
Basic $0.13 $(0.03) $0.30 $(0.01)
Diluted $0.12 $(0.03) $0.28 $(0.01)
Shares used to compute
net income per share:
Basic 55,328 53,808 54,702 53,303
Diluted 63,993 53,808 62,979 53,303
The following table reconciles the specific items excluded from GAAP
net income in the calculation of non-GAAP net income for the periods shown
below:
THORATEC CORPORATION
Reconciliation of GAAP to Non-GAAP Net Income
(Unaudited)
(in thousands, except for per share data)
Three Months Ended Nine Months Ended
Net income (loss) September 27, September 29, September 27, September 29,
reconciliation 2008 2007 2008 2007
Net income (loss)
on a GAAP basis $7,182 $(1,408) $16,182 $(430)
Share-based
compensation
expense:
- Cost of
product sales 371 456 1,284 1,193
Share-based
compensation
expense:
- Selling,
general and
administrative
'/>"/>
| SOURCE Thoratec Corporation Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Thoratec Schedules Third Quarter 2008 Conference Call, Webcast
2. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
3. Thoratec Presentation at JP Morgan Conference to be Webcast
4. Thoratec Announces Appointment of Steven H. Collis to Board of Directors
5. Thoratec Presentation at Bear Stearns Conference To Be Webcast
6. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
7. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
8. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
9. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
10. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
11. United Therapeutics Reports Third Quarter 2008 Financial Results
Post Your Comments:
(Date:5/22/2013)... CANTON, Mass. and NEW ORLEANS ... commercial leader in the field of regenerative medicine, presented ... expert economists from Analysis Group (a leading health economics ... that diabetic foot ulcers (DFU) and venous leg ulcers ... The results of this research, which reveal annual ...
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) ... are pleased to announce a sponsorship agreement with Erebus ... Zealand distributor of DrugCheck® onsite testing devices, manufactured by ... the Austin 400 May 17-19 in Austin, Texas. , ... involves each car of the Erebus Motorsport team displaying ...
(Date:5/22/2013)... , May 22, 2013 Moderna Therapeutics, the pioneering ... modality to enable the in vivo production ... Reynders will join Moderna in early July ... Reynders is a proven leader in the design and ... development, from discovery to translation, clinical operations and commercial ...
(Date:5/21/2013)... 2013 Through science fairs, workshops, kits ... lab equipment, 25 organizations will continue their work to ... and photonics in daily life with the aid of ... located in 10 countries, are the first of two ... SPIE, the international society for optics and photonics ...
Breaking Biology Technology:Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3[0] Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers[0] Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team[0] Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer[0] Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants
... PALO ALTO, Calif. , Feb. 1 Telik, Inc. ... corporate overview at the 12th Annual BIO CEO & Investor Conference in ... 3:00 p.m. Eastern time ( 12:00 p.m. Pacific time ). ... the Telik website, www.telik.com . , Telik, Inc. of Palo ...
... , LEWISTON, Maine , Feb. ... presented by Amgen is officially open and are accepted through ... event serves as the primary fundraiser for The Patrick Dempsey ... Center, in Lewiston, ME , which provides free support, ...
... FORT LAUDERDALE, Fla. , Feb. 1 ... (EuroIntervention, 2010; 5:698-702) demonstrated good safety and efficacy, ... thrombosis at one year in patients with ST-elevation myocardial ... and implantation of the company,s Genous Bio-engineered R stent. ...
Cached Biology Technology:Dempsey Challenge Participant Registration Officially Open 2Dempsey Challenge Participant Registration Officially Open 3Dempsey Challenge Participant Registration Officially Open 4OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI 2OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI 3(Date:5/21/2013)... genes function without changing the underlying DNA sequence, ... pregnant women during any trimester, potentially providing a ... after giving birth, and an opportunity to intervene ... the small study involving 52 pregnant women are ... . , "Postpartum depression can be harmful to ...
(Date:5/20/2013)... the effect of physical education (PE) on child weight, ... increasing the amount of time that elementary schoolchildren spent ... The study represents some of the first evidence of ... is forthcoming in the Journal of Health Economics ... can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The ...
(Date:5/20/2013)... grant will help establish the Center for Advanced Research ... of Illinois at Urbana-Champaign and Worcester Polytechnic Institute (WPI) ... research in drying moist, porous materials such as food ... products; textiles; and biopharmaceuticals," said Hao Feng, a U ... and the Illinois site director. , According to Feng, ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3Gym class reduces probability of obesity, study finds for first time 2NSF approves planning grant for Center for Advanced Research in Drying 2... . , New research explains how cells regulate their ... time, the role of the protein Raf-1 in determining the strength ... at the Max F. Perutz Laboratories, a joint venture of the ... Raf-1 is not present, the cells cannot stick together and the ...
... Two-timing is nothing out of the ordinary for them: ... breeding in a three-gender system. This was discovered by Dr. ... Geobotany Laboratory in cooperation with colleagues from the Heinrich Heine ... structure of the responsible regions in the genome has hardly ...
... Nitrogen is both an essential nutrient and a ... fertilizer that feeds billions, a benefit and a hazard, ... transportation have spread nitrogen liberally around the planet, say ... Issues in Ecology series, "Excess Nitrogen in the ...
Cached Biology News:Essential protein for the formation of new blood vessels identified 22-timing and hybrids: RUB researchers look back on 100 million years of evolution 2Solutions for a nitrogen-soaked world 2Applications: (+) Immunocytochemistry and immunohistochemistry...
For the quantitative determination of canine Interferon gamma,(IFN-γ) concentrations in cell culture supernates, serum and,plasma....
Non-Protein Peroxidase Stabilizer , 1 L...
... Rabbit Reticulocyte Lysate contains the cellular components ... acids, initiation, elongation and termination factors) but ... Untreated Lysate is used primarily for the ... abundant source of endogenous globin mRNA. Untreated ...
Biology Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |